Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1996-1-4
|
pubmed:abstractText |
Antigenic potential of iodixanol, a new non-ionic contrast agent, was evaluated by systemic anaphylaxis (SA) test and homologous passive cutaneous anaphylaxis (Homo-PCA) test using guinea pigs and IgE mediated heterologous PCA (Hetero-PCA) test using rats passively sensitized with mouse sera. SA test was conducted in guinea pigs sensitized with iodixanol at dose levels of 32 or 320 mgI/kg emulsified with Freund's complete adjuvant, followed by challenge with iodixanol (320 mgI/kg). Four- or 24-hr Homo-PCA test was performed with sera from the sensitized animals. Neither positive SA nor Homo-PCA reaction was observed. Hetero-PCA test was performed with the sera from the mice which were sensitized with iodixanol (32 or 320 mgI/kg) with aluminum hydroxide gel. No positive Hetero-PCA reaction was detected in the sera, followed by challenge with iodixanol (320 mgI/kg). Thus, it is concluded that iodixanol possesses no antigenic potential under the present experimental conditions.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0388-1350
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
117-23
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7490783-Anaphylaxis,
pubmed-meshheading:7490783-Animals,
pubmed-meshheading:7490783-Contrast Media,
pubmed-meshheading:7490783-Female,
pubmed-meshheading:7490783-Guinea Pigs,
pubmed-meshheading:7490783-Mice,
pubmed-meshheading:7490783-Passive Cutaneous Anaphylaxis,
pubmed-meshheading:7490783-Rats,
pubmed-meshheading:7490783-Rats, Sprague-Dawley,
pubmed-meshheading:7490783-Triiodobenzoic Acids
|
pubmed:year |
1995
|
pubmed:articleTitle |
[Antigenicity study of iodixanol, a new non-ionic contrast medium].
|
pubmed:affiliation |
Drug Safety Research Center, Developmental Research Laboratories, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
English Abstract
|